Select Medical (NYSE:SEM) Announces Earnings Results

Select Medical (NYSE:SEMGet Rating) issued its quarterly earnings results on Thursday. The health services provider reported $0.43 earnings per share for the quarter, missing analysts’ consensus estimates of $0.51 by ($0.08), Briefing.com reports. Select Medical had a net margin of 5.45% and a return on equity of 24.70%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the previous year, the company posted $1.22 earnings per share. Select Medical’s revenue was up 1.3% compared to the same quarter last year. Select Medical updated its FY 2022 guidance to EPS.

Select Medical Price Performance

NYSE SEM traded up $1.12 on Friday, reaching $28.27. The company’s stock had a trading volume of 1,525,366 shares, compared to its average volume of 816,151. The company has a debt-to-equity ratio of 2.73, a quick ratio of 1.05 and a current ratio of 1.05. Select Medical has a twelve month low of $21.40 and a twelve month high of $40.20. The stock has a market cap of $3.69 billion, a PE ratio of 11.17, a PEG ratio of 0.90 and a beta of 1.31. The firm’s 50 day moving average is $25.64 and its two-hundred day moving average is $24.38.

Wall Street Analysts Forecast Growth

Separately, Credit Suisse Group cut their price target on shares of Select Medical to $27.00 and set a “neutral” rating for the company in a report on Tuesday, May 17th.

Institutional Trading of Select Medical

Hedge funds have recently bought and sold shares of the company. UBS Group AG lifted its stake in Select Medical by 252.4% during the first quarter. UBS Group AG now owns 2,844 shares of the health services provider’s stock valued at $69,000 after buying an additional 2,037 shares in the last quarter. Point72 Hong Kong Ltd acquired a new position in shares of Select Medical in the 1st quarter valued at about $132,000. Captrust Financial Advisors increased its holdings in shares of Select Medical by 35.5% in the 1st quarter. Captrust Financial Advisors now owns 5,931 shares of the health services provider’s stock valued at $142,000 after purchasing an additional 1,555 shares during the period. Guggenheim Capital LLC acquired a new position in shares of Select Medical in the 1st quarter valued at about $210,000. Finally, Brinker Capital Investments LLC increased its holdings in shares of Select Medical by 16.3% in the 1st quarter. Brinker Capital Investments LLC now owns 11,033 shares of the health services provider’s stock valued at $265,000 after purchasing an additional 1,547 shares during the period. 90.98% of the stock is owned by hedge funds and other institutional investors.

About Select Medical

(Get Rating)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.

See Also

Earnings History for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.